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Abstract
Human endogenous retroviruses (HERVs) have been associated with various neurological and neuropsychiatric disorders.
Transcripts and proteins of at least three HERV groups, HERV-W, ERV9 and HERV-K(HML-2) have been detected repeatedly in
brain samples or cerebrospinal fluid of patients with schizophrenia suggesting that alterations in HERV activity may play a
role in etiopathogenesis. Current therapies otherwise include neuroleptics and/or antidepressants that may induce
epigenetic alterations and thus influence HERV expression. To investigate the effects of these drugs on HERV transcriptional
activity, HERV expression profiles of a broad range of human brain cell lines treated with valproic acid (VPA), haloperidol,
risperidone, and clozapine were analyzed using a retrovirus-specific microarray and qRT-PCR. Investigation of 52 HERV
subgroups revealed upregulation of several class I and class II HERV elements by VPA in a dose-dependent manner. The
strongest effect was observed on HERV-W and ERV9 groups in the human glioblastoma cell lines SK-N-SH and SK-N-MC,
respectively. The transcript level of HERV-K(HML-2) elements was not influenced. Transcription of HERV-W, ERV9 and HERV-
K(HML-2) taxa was further quantified in postmortem brain samples of patients with schizophrenia, bipolar disorders and a
healthy control group with regard to their medication. Patients with schizophrenia showed a significantly higher HERV-W
transcription associated with VPA treatment. However in case of ERV9, enhanced transcript levels could not be explained
solely by VPA treatment, since a slight increase was also found in untreated patients compared to healthy controls. HERV-
K(HML-2) elements appeared to be upregulated in some patients with bipolar disorders independent from medication. In
conclusion, these results suggest that antipsychotic medication may contribute to increased expression of distinct HERV
taxa in patients with neuropsychiatric diseases.
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Introduction
Schizophrenia is a highly complex and severe neuropsychiatric
disorder with uncertain etiology. Based on data sets from family,
twin, and adoption studies, as well as from epidemiological
surveys, the etiopathogenesis of schizophrenia involves the
interplay of polygenic influences and environmental risk factors
operating on brain maturation during pregnancy [1,2,3,4].
Susceptibility to environmental factors may be under genetic
control and, vice versa, environmental factors can influence the
genomic imprint leading to altered gene expression. Moreover,
such epigenetic alterations may be vertically transferred to
offspring [5]. Environmental factors such as winter-spring births,
perinatal infections, household crowding, upbringing in urban
areas, and pet ownership support the concept that schizophrenia
could be triggered by infectious agents affecting the brains of
genetically susceptible individuals [1,6,7,8,9].
Retroviruses are candidate infectious agents in CNS diseases of
unknown etiology because of their neurotropism and latency
(reviewed in [10,11]). In particular human endogenous retrovi-
ruses (HERVs) have been repeatedly associated with schizophre-
nia and other neurological diseases (reviewed in [6]). HERVs are
natural components of the human genome constituting at least 8%
of human DNA. They are considered remnants of ancient germ
line infections by exogenous retroviruses that have been genetically
fixed and transmitted in a Mendelian fashion [12,13]. During
evolution, these elements were amplified and spread throughout
the genome by repeated events of retrotransposition and/or
reinfection. To date, they comprise about 500,000 elements [14].
Efficient cellular mechanisms have evolved to restrict their
intracellular activities, including epigenetic mechanisms such as
DNA methylation and chromatin remodeling, as well as
posttranscriptional processing and RNA interference [15,16,17].
However, at least some members of most HERV groups were
found to be still transcriptionally active in a tissue-specific manner
[18,19].
In brain samples, cerebrospinal fluid and blood of patients with
schizophrenia and schizoaffective disorders elevated levels of
transcripts and/or proteins from at least three HERV groups,
HERV-W, ERV9 and HERV-K(HML-2), have been repeatedly
detected [20,21,22,23,24,25,26]. This suggests failure of the
cellular control mechanisms leading to activation or upregulation
of distinct HERV elements in schizophrenia.
However, most schizophrenic patients had obtained antipsy-
chotic medication for years [20,22,24,26]. Even first episode
patients or patients with resent-onset schizophrenia were on
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[22,23,25]. Therefore, irrespective to the question whether the
observed alterations in HERV activity are causative or a
consequence of the disease, a severe imponderability in appraising
experimental data is the treatment of patients with neuroleptics
and/or antidepressants known to influence gene expression by
inducing epigenetic modifications [27,28]. Thus, the question
arises whether the overrepresentation of certain HERV transcripts
in brain tissue from patients with schizophrenia may be due to the
effects of drugs rather than to the disease.
To address the potential impact of medication on HERV
activity we analyzed the HERV transcription pattern in a broad
range of human brain cells (glioblastoma, neuroblastoma, neural
stem cell lines) treated with different concentrations of valproic
acid (VPA), haloperidol, risperidone, and clozapine by means of a
retrovirus-specific microarray (RetroArray) and quantitative
reverse transcriptase PCR (qRT-PCR). Data derived from cell
culture experiments were then compared with the HERV activity
in 56 postmortem brain samples with regard to medication of the
respective patients.
Results
To investigate the influence of antipsychotic drugs on HERV
expression, different human brain cell lines were selected for cell
culture models including glioblastoma cells (U-138MG and U-
251MG), neuroblastoma cells (SK-N-SH and SK-N-MC), and the
human neural stem cell line HNSC.100. All cell lines showed
nearly the same HERV core transcription profile composed of 12
HERV subgroups of class I and II HERVs that has been
established previously for human brain tissue [20] (Table S1). All
cell lines were treated with different doses of VPA. U-138MG, SK-
N-SH, and HNSC.100 cells were additionally treated with
haloperidol, risperidone, or clozapine. The drugs were used in
concentrations that comply with clinically relevant doses [28] and
are non-cytotoxic as determined by a MTT-assay. All further
experiments were performed with RNA samples from at least two
independent treatments. Alterations of HERV transcription
patterns were monitored with a retrovirus-specific microarray
that allows simultaneous detection of 52 representative HERV
subgroups of class I (gammaretrovirus-related), class II (betare-
trovirus-related), and class III (spumaretrovirus-related) HERVs
[19,29]. A representative microarray experiment of cells treated
with 1 and 5 mM VPA is shown in Figure 1. Beside the brain core
HERV profile defined in [20], which consists of HERV taxa with
ubiquitous activity (HERV-E, HERV-F, ERV9 and HERV-K)
some rarely transcribed HERV elements (members of HERV-T,
HERV-FRD, HML-1, HML-2, HML-5, and HERV-L groups)
were detected. A dose-dependent up-regulation of transcription
activity upon treatment with VPA was observed for several class I
groups (HERV-E, HERV-H, HERV-W, ERV9, HERV-F) and
class II HERV groups (HML-3, HML-4, HML-6, HML-9, HML-
10) (Figure 1).
Table 1 summarizes the transcriptional activity of HERV
taxa after treatment of the cells with VPA, haloperidol,
risperidone, or clozapine each att h eh i g h e s tc o n c e n t r a t i o n .I n
contrast to VPA, treatment with haloperidol or risperidone led
only to a slight activation of HERV-E, RGH2 (group HERV-
H), HERV-Fb (group HERV-F), HERV-W, ERV9 (group
ERV9), HML-9 and HERV-KC4 (group HML-10). In case of
haloperidol a dose-dependent upregulation of HERV-Fb was
observed particularly in SK-N-SH cells. Clozapine showed
slightly increased activitieso fE R V 9a n dH E R V - K C 4( g r o u p
HML-10). Remarkably, members of the HML-2 group appear
not to be influenced by any medication in all cell lines according
to HERV Chip data.
To confirm and quantify the microarray results qRT-PCR was
performed for HERV taxa HERV-W, ERV9 (group ERV9),
HERV-F, HML-2, Seq26 (group HML-3) and HERV-KC4
(group HML-10) (boxed in red in Figure 1 and indicated by an
asterisk in Table 1). Specific primer pairs derived from the pol gene
were used for groups HERV-W and HERV-F, subgroup-specific
pol primers for ERV9, Seq26 and HERV-KC4 [19]; M.
Vincendeau, unpublished data). For HERV-K(HML-2) group-
specific primers derived from the gag gene were used enabling a
strict discrimination to other HERV-K groups.
QRT-PCR was carried out with RNA from U-138MG, U-
251MG, SK-N-SH, SK-N-MC and HNSC.100 cells treated with
1 mM and 5 mM VPA in two independent experiments. The
average increase of the relative transcription of six HERV taxa at
a concentration of 5 mM VPA is summarized in Figure 2 A.
Detailed data are shown in Figure S1 and Table S2. In all
glioblastoma and neuroblastoma cell lines, a VPA dependent
upregulation of at least one HERV subgroup was observed. In U-
251MG cells HERV-W, ERV9, HERV-F as well as Seq26 were
found to be upregulated up to six fold compared to untreated cells.
A dramatic alteration of HERV activity was observed in
neuroblastoma cells. HERV-W transcription was increased on
average 22-fold in SK-N-SH cells, and ERV9 18-fold in SK-N-
MC cells after treatment with VPA. In the neural stem cell line
HNSC.100 no significant upregulation was observed, but a very
high VPA dependent activity of the cell cycle control gene p21
(data not shown). No significant influence of VPA on the
transcription activity of the HERV-K(HML-2) group was found.
In contrast to VPA, the typical neuroleptic haloperidol as well as
the atypical neuroleptics risperidone and clozapine showed nearly
no effect on HERV transcription (Figure 2 B). Only HERV-F
appeared to be slightly upregulated in SK-N-SH after treatment
with haloperidol and in HNSC.100 cells after addition of
risperidone; HERV-W in U-138MG cells after treatment with
clozapine.
The HERV groups HERV-W, ERV9 and HERV-K(HML-2)
have been repeatedly associated with schizophrenia. As VPA
showed a significant influence on HERV-W and ERV9 transcrip-
tion but not on HERV-K(HML-2) in cell culture models, we
further investigated the transcription of ERV9, HERV-W, and
HERV-K(HML-2) in postmortem brain samples of patients with
schizophrenia and bipolar disorders with regard to their
antipsychotic medication (Figure 3). QRT-PCR was performed
on RNA samples from the Stanley Array Collection [8] previously
used for microarray experiments [20]. 18 samples of patients with
schizophrenia, 20 samples of patients with bipolar disorders, and
18 healthy controls were examined.
A slight but not significant increase of ERV9 and HERV-
K(HML-2) transcription was observed in both patient groups
under VPA treatment. A significant up-regulation of HERV-W
transcription was detected in schizophrenic patients obtaining
VPA. Independent of the medication, transcription of ERV9 was
found significantly increased in patients with schizophrenia and
bipolar disorders compared to the healthy control group. Likewise,
transcript levels of HERV-K(HML-2) elements were elevated in
patients with bipolar disorders with and without VPA treatment.
The transcription of HERV-W was not significantly higher in both
patient groups.
To exclude that alcohol or drug abuse may influence the data,
we further grouped the patients according to drug or alcohol
abuse. No significant influence of alcohol or drug consumption on
HERV Transcription in Brain Cells
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observed (Figure S2).
Discussion
HERVs, in particular HERV-W, ERV9, and HERV-K(HML-
2) have been associated with schizophrenia and other neurological
diseases [20,21,22,24,25]; reviewed in [6]. Elevated levels of
HERV transcripts and/or proteins detected in brain samples,
plasma or cerebrospinal fluid of patients might be etiologic factors
or a consequence of the disease. Moreover, they could be
indicators for epigenetic changes induced by medication influenc-
ing the epigenetic environment.
Using a retrovirus-specific microarray as well as qRT-PCR we
have investigated the influence of antipsychotic drugs on HERV
transcription in five brain derived cell lines including neural stem
cells, gliobastoma and neuroblastoma cells. No or only slight
effects were observed for haloperidol, risperidone, and clozapine.
In contrast, VPA increased the transcription of many HERVs,
including members of groups ERV9 and HERV-W. VPA is a
histone deacetylase inhibitor and thus may cause chromatin
remodeling around HERV promoters leading to enhanced
expression. Previous investigations have shown that VPA induces
chromatin modifications and, in combination with other antipsy-
chotics, alteration of DNA methylation patterns in patients with
schizophrenia and bipolar disorders [30,31,32]. Interestingly, in
our study the effects of VPA appear to be cell type-dependent and
are predominantly observed in both neuroblastoma cell lines. SK-
N-SH and SK-N-MC differ in several features, for example in
expression levels of dopamine-beta-hydroxylase [33], suggesting a
differential epigenetic background. This might explain that
transcription of two different HERV groups, HERV-W and
Table 1. Influence of antipsychotic medication on HERV activity in human brain cell lines.
HERV medication
valproic acid haloperidol risperidone clozapine
U138 U251 SKNSH SKNMC HNSC U138 SKNSH HNSC U138 SKNSH HNSC U138 SKNSH HNSC
HERV-I 2 2 2 2 222 222 222 2
HERV-T 22 /+ 2/0 22 2 /0 0/+ 22 /0 22 2 /0 0 2
HERV-FRD 222 /0 22 2 /0 2 222 222 2
HERV-E +/0 +/0 ++ /0 +++ /0 0/2 0/+ 00 0 00 / +
RGH2(HERV-H) 00 / 2 0/+ 0/+ 0/2 00 0 / 22 0 + 2/0 0 0/+
HERV-ADP 2 2 2 2 222 222 222 2
HERV-Fb(HERV-F)* ++/0 2/++ ++ 2/++ /0 +/0 +/++ + + 00 / ++ /0 0 0/+
HERV-W* 0/+ 0/++ /0 0 0/++ + + 0/2 + 00 0 00 / +
HERV-R 2 2 2 2 222 222 222 2
ERV9* +++ + /++ /++ + + + +/0 +/0 0 0 + 00 / +
HML-1 220/22 2 2 22 /0 22 222 2
HML-2* 2 2 2 2 222 222 222 2
Seq26 (HML-3)* +/0 ++/0 ++/++ /++ +/0 0 0 2/0 +/0 0 0 2 0 +/0
HML-4 +/0 ++ /0 0/+ 00 / + 0/+ 0/2 0/+ 00 0 00
HML-5 0 2 + 2/0 0/2 0/22 2 0/22 2 2 2 2
HML-6 +/0 ++ /0 0/++ 0/+ 0 000 000 0 / +
HML-7 2 2 2 2 222 222 222 2
HML-8 2 2 2 2 222 222 222 2
HML-9 +/0 +/2 0/+ 2/+ 2/0 2/0 0 2/0 0 0 + 00 0 / +
HERV-KC4(HML-10)* ++/0 +/++ + 0/++ /0 +/0 0/+ 0/++ /0 + 0/+ 0 + 0/+
HERV-L 2 2 2 2 222 222 222 +/2
Two glioblastoma cell lines (U-138MG and U-251MG), two neuroblastoma cell lines (SK-N-SH and SK-N-MC) and the human neural stem cell line HNSC.100 were treated
with 5 mM VPA and compared to untreated cells. U-138MG, SK-N-SH and HNSC.100 were also treated with 10 mM haloperidol, risperidone, or clozapine. Data were
obtained from at least two microarray experiments of each of two independent antipsychotic drug treatments. Varying results for the two treatments are indicated by a
backslash.
2 no expression; 0 no influence; + weak influence; ++ strong influence.
Abbreviations: U138 (U-138 MG), U251 (U-251 MG), SKNSH (SK-N-SH), SKNMC (SK-N-MC), HNSC (HNSC.100).
*HERV subgroups selected for quantification by qRT-PCR.
doi:10.1371/journal.pone.0030054.t001
Figure 1. HERV transcription activity in different human brain cell lines after treatment with valproic acid. 15 representative examples
of false-color microarray data sets representing untreated and treated (1 or 5 mM VPA) samples from different cell lines were aligned. For detailed
information about the identity of microarray capture probes see references [19,20]. Each positive spot on the microarray represents multiple HERV
loci assigned to one subgroup of multicopy HERV elements with sufficient sequence homology that they cannot be distinguished on an individual
basis. The housekeeping gene HPRT served as an internal control. Quantitative RT-PCRs were performed for a subset of six differentially active taxa
(HERV-W, ERV9, HERV-F, HML-2, Seq26, and HERV-KC4 indicated by red boxes.
doi:10.1371/journal.pone.0030054.g001
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PLoS ONE | www.plosone.org 4 January 2012 | Volume 7 | Issue 1 | e30054Figure 2. Relative transcriptional activity of selected HERV taxa in human brain cell lines. Cells were treated with (A) 5 mM VPA and (B)
10 mM haloperidol, risperidone, or clozapine, and compared to untreated cells. QRT-PCR experiments were performed on RNA samples that were
obtained from two independent treatments with VPA, haloperidol, risperidone, or clozapine previously used for the retrovirus-specific microarray.
Relative transcription levels were quantified according to Pfaffl et al. [41]. For amplification of HERV-K(HML-2) transcripts primers derived from the gag
region were used. Transcription of other HERV subgroups was analyzed using pol specific primers overlapping with the capture probes of the
microarray. The level of HERV transcripts was normalized to RPII and represents the mean value of at least triplicate qRT-PCR experiments. Numbers
on the Y-axis show the fold up-regulation. A less than 2.5-fold increase of transcript levels is not considered as a significant transcriptional activation.
doi:10.1371/journal.pone.0030054.g002
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respectively.
Transcription of group HERV-K(HML-2) is not significantly
influenced by any drugs in all cell lines investigated. In a previous
study, expression profiling of a broad range of HERVs in brain
samples from patients with schizophrenia and bipolar disorders
using the retrovirus-specific microarray revealed a significant
overrepresentation of HERV-K(HML-2) transcripts in both
patient groups compared to healthy controls [20]. To verify these
data, and to reassess a possible influence of antipsychotic drugs, we
used the same patient material for qRT-PCR. Sorting the data
according to patient medication we observed a bias to an increased
transcriptional activity of ERV9 and HERV-W in brain tissue of
schizophrenic patients treated with VPA in comparison to
untreated patients. In addition to the effect of VPA, a slight
elevation of ERV9 transcripts was observed in both patient groups
compared with healthy controls. Independent of the medication, a
significant upregulation of HERV-K(HML-2) transcription was
found in some patients with bipolar disorders. These data suggest
that transcriptional activation of certain retroviral elements might
be associated with the disease at least in some cases. However,
these data should be interpreted with caution because many
confounding factors, demographic and clinical variables, may
conceal the outcome of the experiments [27] Such imponderabil-
ities may also explain differential findings of recently published
studies [20,21,22,24,25]. Drug abuse and alcohol, the parameters
Figure 3. Quantification of HERV transcription in 56 postmortem brain samples by qRT-PCR. Transcriptional activities of ERV9 (A), HERV-
W( B), and HML-2 (C) were analyzed in a subset of 18 schizophrenia-derived brain samples and 20 samples of patients with bipolar disorders with
regard to VPA treatment, and compared to 18 healthy individuals. The level of HERV transcripts in each sample was normalized to RPII levels and
represents the mean value of at least triplicate experiments. Significant deviation between patient groups according to the Student’s t-test is
denoted for each HERV taxon by * p#0.05, ** p#0.01, *** p#0.001).
doi:10.1371/journal.pone.0030054.g003
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but did not show relevant differences.
Taken together, our data suggest a complex regulation of
HERV activity in human brain cells. Differential HERV
expression in patients may depend on environmental factors
including epigenetic drugs, as well as pathologic conditions.
Moreover, individual variation of epigenetic patterns may play a
role. Most HERVs constitute multicopy families, e. g. HERV-
K(HML-2) comprises around 60 different loci per haploid human
genome, 16 of which are differentially transcribed in human brain
[34]. Groups HERV-W and ERV9 represent about 40 and 300
proviral copies, respectively. Each provirus of one HERV group
might be differentially expressed under varying epigenetic
environments. This could explain inconsistent results obtained in
different experimental settings. An interesting hypothesis is that
transcriptional activation of many defective HERV copies may
interfere with few protein coding HERVs [26]. This could for
example be provoked by antisense HERV transcripts expressed
from adjacent cellular promoters [34] or bidirectional HERV
promoters [35]. Such a self-regulating mechanism may constitute
a complex network of HERV transcriptional control that has
helped HERVs to escape purifying selection during evolution.
Materials and Methods
Human brain RNA samples
Total RNA samples derived from the prefrontal cortex
(Brodmann’s area 46) of 12 patients with schizophrenia, 20
patients with bipolar disorders and 18 healthy controls (The
Stanley Array Collection) were kindly provided by the Stanley
Medical Research Institute, Bethesda, MD. The Stanley Medical
Research Institute reassures that in all cases the next of kin gave
permission in writing to examine the brains for research purposes.
A detailed statement about the Stanley Brain Collection can be
obtained from the Institute’s website at www.stanleyresearch.org.
Cell lines and drug treatment
The human glioblastoma cell lines U-138MG (HTB-16) and U-
251MG (HTB-17), the human neuroblastoma cell lines SK-N-SH
(HTB-11) and SK-N-MC (HTB-10), and the human neural stem
cell line HNSC.100 [36] were purchased from ATCC or
authenticated by the German Collection of Microorganisms and
Cell Cultures (DSMZ, Braunschweig, Germany) and cultured as
recommended. Cell culture media were supplemented with 10%
fetal calf serum and penicillin-streptomycin at a concentration of
100 mg/ml. All cells were routinely tested for mycoplasma
contamination using LookOut Mycoplasma PCR Detection Kit,
Sigma. Cells were treated with 1 and 5 mM valproic acid (VPA) or
0.1, 1 and 10 mM haloperidol, risperidone, or clozapine (Sigma-
Aldrich, Steinheim, Germany) for 24 h. U-251MG cells were
additionally treated with 1 and 5 mM VPA for 72 h. The
concentrations were non-cytotoxic as determined by a colorimetric
MTT assay in 96 well plates as described [37]. As controls
untreated cells of the same passage were cultivated in parallel with
each experiment.
RNA Preparation, DNAse treatment, and cDNA synthesis
Total RNA was isolated from cultured cells using the RNeasy
Kit according to manufacturer’s instructions (Qiagen, Hilden,
Germany). To exclude DNA contamination, RNA samples were
treated with 100 units/mg RNase-free DNase using the RQ1
DNase Kit (Promega, Mannheim, Germany) and tested by PCR
with mixed oligonucleotide primers [19]. Only DNA-negative
RNA samples (1–2 mg) were subsequently transcribed using
SuperScript II First-Strand Synthesis according to the manufac-
turer’s instructions (Invitrogen, Karlsruhe, Germany).
Retrovirus-specific microarray (RetroArray)
Hybridization probe synthesis and labeling by MOP-PCR, as
well as DNA chip preparation, hybridization, and postprocessing
of retrovirus-specific microarrays were performed as described
previously [18,19,20]. Hybridized microarrays were scanned using
an Affymetrix Scanner GMS 418 (laser power 100%, gain 50–
60%) and false color mapping was used for image visualization.
Quantification of HERV transcripts by qRT-PCR
For the amplification of pol(RT) sequences, specific primers for
groups HERV-W (forward primer: TGAGTCAATTCTCA-
TACCTG, reverse primer: AGTTAAGAGTTCTTGGGTGG)
and HERV-F (forward primer: CCTCCAGTCACAACAACTC,
reverse primer: TATTGAAGAAGGCGGCTGG) were used.
Subgroup-specific primers were employed for ERV9 (group
ERV9) (forward primer: CCTCAACTGTTTTAATGTCT-
TAGGGCGAGG, reverse primer: CCCTCATCTGTTTGGT-
CAGGCCC), Seq26 (group HML-3) (forward primer: CTGC-
AGCCTGCTAAGCG, reverse primer: CACTGTGAAA-
ATTTTTTACGAG), and HERV-KC4 (group HML-10) (for-
ward primer: GAATCTCTTCTAATTTGAACCTTTTGAGG,
reverse primer: CCCACAGTTTGTCAAACTTTTGTAGGC)
[19]; M. Vincendeau, unpublished data). For group HERV-
K(HML-2), gag specific primers were used for quantification
(forward primer: GGCCATCAGAGTCTAAACCACG, reverse
primer: CTGACTTTCTGGGGGTGGCCG). As a control for
VPA treatment p21 was quantified as described [38].
QRT-PCR was performed with the Roche LightCycler 480
System, using LC480 DNA Master SYBR Green and the standard
LightCycler protocol (Roche Diagnostics, Mannheim). A 10-
minute initial denaturation step at 95uC was followed by 50
amplification cycles of 10 s at 95uC, 5 s at 60uC, and 10 s at 72uC.
Melting curves were generated for the final PCR products by
decreasing the temperature to 65uC for 15 s followed by an
increase in temperature to 95uC. Fluorescence was measured at
0.2uC increments. RNA-Polymerase II (RPII) transcripts were
analyzed as internal standards [39]. DCT-values were calculated as
follows: CT(RPII)-CT(HERV element), and were normalized to
RPII levels. The x-fold induction of HERV transcription in
treated cells was calculated by the 2
2DDCT method [40], with
values normalized to RPII and relative to transcription in non-
treated cells. The relative HERV transcription ratio of postmor-
tem samples was calculated from the qRT-PCR efficiencies and
the crossing point deviations of the target gene versus the
housekeeping gene RPII [41]. Quantitative RT-PCR experiments
for each gene were performed at least in triplicate.
Supporting Information
Figure S1 Quantification of HERV transcription in
human brain cell lines by qRT-PCR. Transcriptional
activities of HERV-W (A), HML-2 (B), ERV9 (group ERV9)
(C), Seq26 (group HML-3) (D), HERV-F (E), and HERV-KC4
(group HML-10) (F) were analyzed in cell lines after treatment
with 1 and 5 mM VPA in comparison to untreated cells. Relative
transcription levels were quantified according to the method of
Pfaffl et al. [41]. For amplification of HERV-K(HML-2)
transcripts primers derived from the gag region were used.
Transcription of other HERV subgroups was analyzed using pol
specific primers overlapping with the capture probes of the
microarray. The level of HERV transcripts in each sample was
HERV Transcription in Brain Cells
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triplicate experiments of two independent treatments.
(TIF)
Figure S2 HERV transcriptional activity in 56 postmor-
tem brain samples with regard to heavy alcohol or drug
use analyzed by qRT-PCR. Transcriptional activities of ERV9
(A), HERV-W (B), and HML-2 (C) in brain samples of patients
with schizophrenia, bipolar disorders and healthy individuals
(Figure 3) were grouped according to heavy alcohol or drug use
irrespective of the disease and VPA treatment. No significant
differences in HERV transcription were observed.
(TIF)
Table S1 Baseline HERV activity in different human
brain cell lines.
(PDF)
Table S2 Relative transcriptional activity of six selected
HERV taxa in human brain cell lines after treatment
with 5 mM VPA, 10 mM haloperidol, risperidone, or
clozapine.
(PDF)
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